RO5166017

来自Local Chinese Wikipedia
imported>Htmlzycq2025年1月29日 (三) 08:52的版本 (使用HotCat已移除Category:胺; 已添加Category:叔胺
(差异) ←上一版本 | 最后版本 (差异) | 下一版本→ (差异)
跳转到导航 跳转到搜索
RO5166017
File:RO5166017 structure.png
臨床資料
藥物類別Trace amine-associated receptor 1 (TAAR1) partial or near-full agonist
识别信息
  • (S)-4-[(ethyl-phenyl-amino)-methyl]-4,5-dihydro-oxazol-2-ylamine
CAS号1048346-74-2
PubChem CID
ChemSpider
UNII
化学信息
化学式C12H17N3O
摩尔质量219.29 g·mol−1
3D模型(JSmol
  • NC1=N[C@@H](CN(C2=CC=CC=C2)CC)CO1
  • InChI=1S/C12H17N3O/c1-2-15(11-6-4-3-5-7-11)8-10-9-16-12(13)14-10/h3-7,10H,2,8-9H2,1H3,(H2,13,14)/t10-/m0/s1
  • Key:PPONHQQJLWPUPH-JTQLQIEISA-N

RO5166017RO-5166017是一种含氮有机化合物,化学式C
12
H
17
N
3
O
,属于一种痕量胺相关受体TAAR1的选择性激动剂[1],由罗氏制药研发[2]

参考文献[编辑]

  1. Revel FG, Moreau JL, Pouzet B, Mory R, Bradaia A, Buchy D, Metzler V, Chaboz S, Groebke Zbinden K, Galley G, Norcross RD, Tuerck D, Bruns A, Morairty SR, Kilduff TS, Wallace TL, Risterucci C, Wettstein JG, Hoener MC. A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight. Mol Psychiatry. May 2013, 18 (5): 543–556. PMID 22641180. doi:10.1038/mp.2012.57. 
  2. Revel FG, Moreau JL, Gainetdinov RR, Bradaia A, Sotnikova TD, Mory R, Durkin S, Zbinden KG, Norcross R, Meyer CA, Metzler V, Chaboz S, Ozmen L, Trube G, Pouzet B, Bettler B, Caron MG, Wettstein JG, Hoener MC. TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity. Proc Natl Acad Sci U S A. May 2011, 108 (20): 8485–8490. Bibcode:2011PNAS..108.8485R. PMC 3101002可免费查阅. PMID 21525407. doi:10.1073/pnas.1103029108可免费查阅.